( en | de | ru )

 

Disambiguierung von "Lagier, Jean-Christophe"

Autor der Publikation

KopierenLöschenDiese Publikation zur Ablage hinzufügen
Early treatment of 1061 COVID-19 patients with hydroxychloroquine and azithromycin, Marseille, France

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , und . (2020)

Bitte wählen Sie eine Person um die Publikation zuzuordnen

Um zwischen Personen mit demselben Namen zu unterscheiden, wird der akademische Grad und der Titel einer wichtigen Publikation angezeigt. Zudem lassen sich über den Button neben dem Namen einige der Person bereits zugeordnete Publikationen anzeigen.

Jean-Christophe Magnan

Jean-Christophe Legrix

Jean-Christophe Legrix

Jean-Christophe Roux

Jean-Christophe Nebel

 

Weitere Publikationen von Autoren mit dem selben Namen

Clinical Efficacy of Chloroquine derivatives in COVID-19 Infection: Comparative meta-analysis between the Big data and the real world, , , , , , , , , und 4 andere Autor(en). New Microbes and New Infections, (2020)Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis, , , , , , , , , und 33 andere Autor(en). Travel Medicine and Infectious Disease, (2020)Re: Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID2 19 patients: a systematic review and meta-analysis, , , und . Clinical Microbiology and Infection, (2020)Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France, , , , , , , , , und 27 andere Autor(en). Travel Medicine and Infectious Disease, (2020)Early treatment of 1061 COVID-19 patients with hydroxychloroquine and azithromycin, Marseille, France, , , , , , , , , und 27 andere Autor(en). (2020)Chloroquine and hydroxychloroquine as available weapons to fight COVID-19, , , , und . International Journal of Antimicrobial Agents, 55 (4): 105932 (2020)Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, , , , , , , , , und 8 andere Autor(en). International Journal of Antimicrobial Agents, 56 (1): 105949 (2020)Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study, , , , , , , , , und 19 andere Autor(en). Travel Medicine and Infectious Disease, (2020)This is the second Marseille study.Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France, , , , , , , , , und 27 andere Autor(en). Travel Medicine and Infectious Disease, (2020)Treatment of classic Whipple's disease: from in vitro results to clinical outcome, , , , , und . Journal of Antimicrobial Chemotherapy, 69 (1): 219–227 (2014)